Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Starts Testing For Over-The-Counter Lipitor
Forbes
Monday, March 3, 2014 - 8:07am
tags:
OTC, statins, Lipitor, Pfizer
This Week in Biotech: 2 FDA Approvals and 3 Clinically Impressive Studies
Motley Fool
Sunday, March 2, 2014 - 11:59am
tags:
Myalept, leptin deficiency, lipodystrophy, Astra Zeneca, Bristol-Myers Squibb, Anika, Monovisc, osteoarthritis, osteoarthritis of the knee
Pharmaceutical company to pay NC $1.5 million for fraud
WNCN, NC
Saturday, March 1, 2014 - 12:25pm
tags:
Endo, legal
Merck: DOJ Ends Bribery Probe
WSJ
Saturday, March 1, 2014 - 12:24pm
tags:
Merck, legal
Is 2014 Going to Be GlaxoSmithKline's Year?
Motley Fool
Saturday, March 1, 2014 - 12:18pm
tags:
GSK
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results
Seeking Alpha
Saturday, March 1, 2014 - 11:58am
tags:
Alzheimer's disease, Prana Biotechnology, PBT2
Pharma Patent Cliff: Why Worst Seems Over
Seeking Alpha
Saturday, March 1, 2014 - 11:56am
tags:
patent cliff, generics
An Update On Acadia Pharmaceuticals
Seeking Alpha
Saturday, March 1, 2014 - 11:54am
tags:
Acadia
Activist Investors Agitating Biotechs Bring Multi-Bagger Returns
Motley Fool
Saturday, March 1, 2014 - 11:53am
tags:
InterMune Stuns Markets, but Is It Overvalued?
Motley Fool
Saturday, March 1, 2014 - 11:51am
tags:
InterMune
Arena Prescription Sales Up: Stops Stock Slide
Seeking Alpha
Saturday, March 1, 2014 - 11:50am
tags:
Arena Pharmaceuticals
3 Stocks Improving Performance Of The Drugs Industry
TheStreet.com
Friday, February 28, 2014 - 12:19pm
tags:
Celgene, Merck, JNJ
Report: Novartis reorganization quietly claims 3,000 jobs in just 4 months
Fierce Biotech
Friday, February 28, 2014 - 12:14pm
tags:
Novartis, layoffs, reorganization
Analysts cheer on Merck's comeback campaign, pumping up blockbuster forecasts
Fierce Biotech
Friday, February 28, 2014 - 12:13pm
tags:
Merck, MK-3475
Endo loss widens, R&D chief departs amid regulatory struggles
Fierce Pharma
Friday, February 28, 2014 - 12:11pm
tags:
Endo Health Solutions, earnings
Questcor continues lower as FDA says reviewing Acthar lab test results
The Fly on the Wall
Friday, February 28, 2014 - 11:58am
tags:
Questcor Pharmaceuticals, FDA, Acthar
Generic-Drug Failures Spur Concern as FDA Steps Up Action
Bloomberg
Friday, February 28, 2014 - 11:56am
tags:
generics, FDA
Small Is Beautiful? Not Without Biotech
Barron's
Friday, February 28, 2014 - 11:54am
tags:
biotech, Intercept Pharma
Merck's NOXAFIL gets positive opinion from CHMP
Yahoo/Fly on the Wall
Friday, February 28, 2014 - 11:50am
tags:
Merck, CHMP, Noxafil, Europe
Ligand says partner GSK submits application for Promacta
Yahoo/Fly on the Wall
Friday, February 28, 2014 - 11:48am
tags:
Ligand Pharmaceuticals, GSK, Promacta

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.